Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Growth 2025-2031

The global Contrast Agents for Magnetic Resonance Imaging (MRI) market size is predicted to grow from US$ 1560 million in 2025 to US$ 2101 million in 2031; it is expected to grow at a CAGR of 5.1% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration.

Global key MRI contrast agents core players include Bayer, Guerbet Group and Bracco Imaging etc. The top 3 companies hold a share about 82%. Asia-Pacific is the largest market with a share about 35%, followed by North America and Europe.

In terms of product, gadoterate meglumine product is the largest segment with a share about 27%. And in terms of applications, the largest application is hospital with a share about 84%.

LP Information, Inc. (LPI) ' newest research report, the “Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Forecast” looks at past sales and reviews total world Contrast Agents for Magnetic Resonance Imaging (MRI) sales in 2024, providing a comprehensive analysis by region and market sector of projected Contrast Agents for Magnetic Resonance Imaging (MRI) sales for 2025 through 2031. With Contrast Agents for Magnetic Resonance Imaging (MRI) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Contrast Agents for Magnetic Resonance Imaging (MRI) industry.

This Insight Report provides a comprehensive analysis of the global Contrast Agents for Magnetic Resonance Imaging (MRI) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Contrast Agents for Magnetic Resonance Imaging (MRI) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Contrast Agents for Magnetic Resonance Imaging (MRI) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Contrast Agents for Magnetic Resonance Imaging (MRI) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Contrast Agents for Magnetic Resonance Imaging (MRI).

This report presents a comprehensive overview, market shares, and growth opportunities of Contrast Agents for Magnetic Resonance Imaging (MRI) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media

Segmentation by Application:
Radiology
Interventional Radiology
Interventional Cardiology

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)

Key Questions Addressed in this Report

What is the 10-year outlook for the global Contrast Agents for Magnetic Resonance Imaging (MRI) market?

What factors are driving Contrast Agents for Magnetic Resonance Imaging (MRI) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Contrast Agents for Magnetic Resonance Imaging (MRI) market opportunities vary by end market size?

How does Contrast Agents for Magnetic Resonance Imaging (MRI) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver. Show more